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Background: Preservatives such as formaldehyde and formaldehyde-releasers are common causes of contact allergy.
Objectives: To examine trends in contact allergy to formaldehyde and formaldehyde-releasers in patch tested patients in Denmark over a 10-year period (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) , and to investigate relevant sources of formaldehyde among the patients.
Methods:
A cross-sectional registry study on patch test data from patients tested with formaldehyde and formaldehyde-releasers (N = 8463) was performed. The presence of released formaldehyde in products from formaldehyde-allergic patients was identified with chemical analyses (chromotropic acid or acetylacetone test).
Results: The prevalence of contact allergy to formaldehyde 1% was 1.5%, and ranged between 0.97% and 2.3%, with a decreasing trend in this 10-year period. Contact allergy to formaldehyde 2% was found in 2.4%, and no significant trend was observed. Quaternium-15 was the formaldehyde-releaser most often positive (0.86%). Patients allergic to formaldehyde often had simultaneous positive patch test reactions to formaldehyde-releasers (36%). Almost 63% of the patients with formaldehyde allergy used products that released formaldehyde; cosmetics were the most common sources.
Conclusions:
Although contact allergy to formaldehyde 1% decreased in this 10-year time period, contact allergies to formaldehyde and formaldehyde-releasers overall remain frequent in patients. In most cases, formaldehyde-allergic patients are exposed to ≥1 products containing formaldehyde. Improved regulation on permitted amounts of free formaldehyde in cosmetics is still warranted, including direct labelling of formaldehyde when it is present in small but relevant amounts.
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| INTRODUCTION
Cosmetic products and toiletries are used daily by most people. Formaldehyde is a preservative that is commonly used in water-based cosmetics to prevent microbial growth. 1 During the 1950s, formaldehyde became a popular preservative because it was efficient and cheap. As a consequence, an increased incidence of contact allergy to formaldehyde was observed (3.9%) in patients from both Western Europe and North America. 2, 3 More recent studies have shown that the prevalence of formaldehyde allergy is approximately 2% to 3% among patch tested patients in Europe. 1, 4, 5 Formaldehyde can be found in products containing formaldehyde-releasers, 2, 6 which release formaldehyde in the presence of water. 5 The recommended patch test concentration of formaldehyde in the baseline series has been discussed for decades, and has gradually been reduced from 4% to 1%. 7 However, clinical studies later showed that patch testing with formaldehyde 2% detects significantly more cases than testing with formaldehyde 1%. 8, 9 It is of note that a repeated open application test was used to evaluate the significance of contact allergy to formaldehyde 2%, and showed it to be clinically relevant. 10 Chemically, formaldehyde-releasers are linear or cyclic reversible polymers of formaldehyde. An allergic reaction can be caused by the entire molecule of a formaldehyde-releaser or the released formaldehyde. 11 The amount of free formaldehyde depends on the specific formaldehyde-releaser, and its concentration and pH, and other components of the product. 5 A previous study from our clinic covering the time period 1985 to 2008 showed that contact allergy to formaldehyde was more prevalent than contact allergy to formaldehyde-releasers; the prevalence of contact allergy to quaternium-15, diazolidinyl urea, imidazolidinyl urea, DMDM hydantoin and 2-bromo-2-nitropropane-1,3-diol varied between 0.6% and 1.6%. 4 In general, preservatives in cosmetics must be declared in the list of ingredients. Moreover, products containing >500 ppm formaldehyde (equivalent to 0.05%) must be labelled with "contains formaldehyde". 12 Despite this, it is difficult for an allergic patient to completely avoid formaldehyde or formaldehyde-releasers, and previous studies have shown that hidden sources of formaldehyde in cosmetics can cause chronic allergic eczema. 1, 6, 10 In this study, we investigated trends in contact allergy to formaldehyde and formaldehyde-releasers in Denmark over a 10-year period. We also examined the types and the number of products that contain formaldehyde used by formaldehyde-allergic patients.
| MATERIALS AND METHODS

| Study population
This study was a registry study on patch test data from patients tested with the European baseline series and an extended baseline series at Figure S1 .
The MOAHLFA index (Male; Occupation; Atopic dermatitis; Hand eczema; Leg eczema; Facial eczema; Age >40 years) 13 and information on the clinical relevance of positive reactions to formaldehyde and formaldehyde-releasers were available for all patients in the study.
Clinical relevance was noted if the detected exposures to formaldehyde or formaldehyde-releasers could partly or fully explain the current dermatitis. 
| Patch testing
| Formaldehyde exposure analyses
Formaldehyde exposure analysis is a routine investigation at our clinic that is offered to patients with positive patch test reactions to formaldehyde. Generally, it is performed only if formaldehyde or formaldehyde-releasers are not present in the list of ingredients.
However, the data from formaldehyde exposure analysis, performed during 2007 to 2016, were not systematically compared with ingredient labelling, which is why information regarding labelling is lacking in this study design. Data on formaldehyde exposure analysis were available for 183 patients. The products from the formaldehyde-positive patients were placed into 4 categories: "cosmetics", "household products", "occupational products", and "other". The existence of formaldehyde or free formaldehyde released from formaldehyde-releasers in the products was primarily verified with the chromotropic acid test. In cases in which the chromotropic acid test was discoloured, the acetylacetone test was used.
A standard solution with, separately, 2. 
| Acetylacetone test
In short, a small sample of the patient's product was placed in a glass jar with a ground-glass stopper, mixed with 2.5 mL of acetylacetone (Gentofte Hospital Pharmacy, Copenhagen), and finally heated at 60 C for 10 minutes. If formaldehyde was present in the product sample, it resulted in a yellow derivative. 3 | RESULTS
| Overall trends in prevalence from 2007 to 2016
The overall prevalence of contact allergy to formaldehyde 1% or 2% was 2.4%. Figure 1 shows the temporal trends in formaldehyde and formaldehyde-releaser allergy; the prevalence of formaldehyde allergy throughout the 10-year period is shown separately for 1%, ranging between 0.97% and 2.3%, and for 2%, ranging between 2.2% and 2.5%
(P trend = .002 and P trend = .57, respectively). The prevalence of contact allergy to quaternium-15 was 0.86% (P trend = .053). The prevalences of contact allergy to diazolidinyl urea and DMDM hydantoin were 0.49% and 0.25%, respectively (P trend = .14 and P trend = .10). The prevalences of contact allergy to the remaining 2 formaldehyde-releasers, imidazolidinyl urea and 2-bromo-2-nitropropane-1,3-diol, showed small but significant decreases, from 0.7% to 0.1% (P trend = .048 and P trend = .007, respectively). Overall, we observed that the prevalence of contact allergy to at least 1 of the investigated allergens did not increase significantly during the study period (P trend = .36). In addition, there was no significant change in occupation-related eczema, age > 40 years or hand eczema among individuals with contact allergy to at least 1 allergen over time (P trend = .74, .052 and .42, respectively).
Prevalences and clinical characteristics of the patient population are shown in Table 1 . Patients allergic to formaldehyde were significantly older than patient not allergic to formaldehyde or formaldehyde-releasers. In detail, the age and sex distribution was as follows. Patients allergic to formaldehyde or formaldehyde-releasers had a median age of 52 years (25th-75th percentiles, 41-60 years), and 23.3% were males. Patients not allergic to formaldehyde or Total prevalences during the 10-year period: formaldehyde (1%), 1.5% (minimum 0.97% to maximum 2.3%, P trend = .002); formaldehyde (2%), 2.4% (minimum 2.2% to maximum 2.5%, P trend = .57); quaternium-15, 0.86% (minimun 0.66% to maximum 1.2%, P trend = .053); imidazolidinyl urea, 0.23% (minimum 0.11% to maximum 0.48%, P trend = .048); diazolidinyl urea, 0.49% (minimum 0.36% to maximum 0.88%, P trend = .14); DMDM hyantoin, 0.25% (minimum 0.16% to maximum 0.56%, P trend = .10); 2-bromo-2-nitropropane-1,3-diol, 0.33% (minimum 0.11% to maximum 0.73%, P trend = .007); contact allergy to at least 1 allergen, 3.0% (minimum 2.6% to maximum 3.4%, P trend = .36)
formaldehyde-releasers, but possibly allergic to other allergens, had a median age of 48 years (25th-75th percentiles, 35-61 years), and 31.5% were males.
Generally, patients with formaldehyde and formaldehydereleaser allergy suffered more often from hand eczema and were significantly older than those without allergies. In detail, 63.0% of the individuals allergic to formaldehyde 1%, and 50.0% of the individuals allergic to formaldehyde 2%, suffered from hand eczema, whereas 68.0% of the individuals allergic to quaternium-15 suffered from hand eczema. In addition to the numbers shown in Table 1 
| Sources of formaldehyde exposure in patient products
Between 2007 and 2016, a total of 3679 products from 183 formalde-
hyde-allergic patients were tested for their formaldehyde content with the chromotropic acid test and/or the acetylacetone test. Formaldehyde was detected in 7.0% of the tested products. The Bold values indicate significance difference from the group not allergic to formaldehyde or formaldehyde-releasers.
distributions of tested products are shown in Table 3 : cosmetics, 76.3%; household products, 3.9%; occupational products, 7.7%; and "other" products, 2.1%. Regarding the products that tested positive for formaldehyde, 66.8% were cosmetics, 23.4% were household products, 9.0% were occupational products, and 0.8% were categorized as "other". The most frequent cosmetic products releasing formaldehyde were creams (35.1%), shampoos (24.0%), and soaps (12.3%) (Table 4 ). In total, 62.8% (n = 115) of the patients with formaldehyde allergy used a product that released formaldehyde. The formaldehyde exposure data were not compared with the ingredient labelling, and the product categories must therefore be regarded only as indicating frequent sources of exposure among formaldehyde-allergic patients.
| DISCUSSION
This study investigated the 10-year trend in contact allergy to formaldehyde and formaldehyde-releasers in Denmark. We found that the prevalence of contact allergy to formaldehyde 1% fluctuated between 0.97% and 2.3% throughout the period. Trends of contact allergy to formaldehyde 1% in Denmark have previously been reported by Thyssen et al (2010) , who found that the prevalence of formaldehyde allergy ranged between 2% and 4% in the time period between 1985 and 2008. 4 In this article, we report an overall decrease in the prevalence of contact allergy to formaldehyde as diagnosed with 1%
aq. between 2007 and 2016. However, there is no evident explanation for the decrease. In contrast, contact allergy to formaldehyde 2% remained stable, with a prevalence ranging between 2.3% and 2.7%, which gives a total prevalence of contact allergy to formaldehyde (1% or 2%) of well above 2%.
A Lithuanian study from 2016 found an increased prevalence of contact allergy to formaldehyde in the period 2006 to 2015 (2.9% versus 4.3%). 17 As pointed out by the authors, this may have been FIGURE 2 One-hundred and twenty-four patients (51.5%) were allergic only to formaldehyde, 46 patients (19.1%) were allergic only to formaldehyde-releasers, and 71 patients (29.4%) were allergic to both formaldehyde and formaldehyde-releasers attributable to the increase in patch test concentration from 1% to 2%
formaldehyde. In our study, we also tested with formaldehyde 2% from 2011, but retained 1% formaldehyde in order to better interpret the patch test reactions. This has given us the unique possibility of looking at these individually and together, and we show that the prevalence of contact allergy to formaldehyde 2% overall was unchanged in the period 2011 to 2016.
In northeastern Italy, the prevalence of contact allergy to formaldehyde was 3.3% (1996-2012, European baseline series), but, as in our study, no significant trend was found over time. 18 Thus, the prevalence of formaldehyde allergy in other parts of Europe still appears to be stable at a high level. This study found that 36.4% of the patients with allergy to formaldehyde also had allergy to ≥1
formaldehyde-releasers. Seventy-five per cent of these patients had a combined formaldehyde/quaternium-15 allergy. A similar distribution of concomitant allergy to formaldehyde and quaternium-15 has been observed in previous studies. Concerning the temporal trends for the formaldehyde-releasers, contact allergy to imidiazolidinyl urea and 2-bromo-2-nitropropane-1,3-diol showed a small but significant decrease in prevalence. However, caution must be applied in the interpretation of these results, as the total numbers of patients with contact allergy to these 2 compounds were 19 and 28, respectively. Hence, small changes in the numbers of patients with positive patch test reactions to formaldehyde-releasers can affect the trend. In line with this, we did not find a significant trend for contact allergy to quaternium-15 when we analysed the 2-year trend, although the P value can be characterized as "borderline significant" (Figure 1 , P trend = .053). Notably, the decreasing trend for contact allergy to formaldehyde 1% was significant irrespective of whether we used the trend test corresponding to a single year or that corresponding to combined years.
The patch test concentration of formaldehyde has been debated for a long time. Results from a multicentre study suggested that the patch test concentration of 1% was too low and may cause falsenegative reactions. 21 In 2013, The ESCD changed its recommendation to increase the formaldehyde concentration to 2.0%, 14 A Danish study from 2010 found that 75% of formaldehydeallergic patients used at least 1 product containing formaldehyde on a daily basis. 19 In our study, we found that 62.8% of the patients diagnosed with formaldehyde allergy and who had their products investigated in the formaldehyde exposure analysis used ≥1 products releasing formaldehyde. The slightly differing results may be attributable to the fact that, in recent years, analyses have not always been performed on products for which formaldehyde or formaldehydereleasers are declared in the list of ingredients. Formaldehyde contact allergy still represents a significant and relevant clinical problem, and it is generally agreed that it is difficult for allergic patients to avoid exposure to formaldehyde-containing products, as formaldehyde is not directly declared in the list of ingredients, but hidden under complicated names of formaldehyde-releasers.
Although we do not know the exact amount of released formaldehyde that is required to cause an allergic reaction, 5 a recent study investigating the effect of low concentrations of formaldehyde on irritant contact dermatitis found that a low level of exposure to formaldehyde is sufficient to worsen existing dermatitis. 6 As it is not obligatory for small amounts of formaldehyde to be declared in the list of ingredients or in the material safety data sheet of the product, the authors suggested that chemical analysis is needed to optimize patient care for formaldehyde-allergic individuals. 6 We agree with this, and add that the most frequent cosmetic products releasing formaldehyde in our analyses were creams and soaps, which might be contributing to the increased prevalence of hand eczema observed in patients with formaldehyde and formaldehyde-releaser allergy, as these products are applied to the body with the hands.
In conclusion, formaldehyde is still an allergen of high concern, and additional measures must be taken to protect formaldehyde-allergic patients. Patients with allergy to formaldehyde should be advised to avoid products containing formaldehyde-releasers, especially quaternium-15. Although product labelling is mandatory, it remains difficult for allergic patients to avoid formaldehyde in their products, and cosmetics must still be considered to be the main sources of exposure.
Meaningful labelling that also indicates the presence of formaldehyde in low but relevant concentrations should therefore be introduced. Hidden sources of formaldehyde can cause chronic allergic eczema, which is why an increased focus on allergy to formaldehyde and formaldehyde-releasers is needed.
